Skip to main content

Peer Review reports

From: Non–small cell lung cancer and immune checkpoint inhibitor therapy: does non-alcoholic fatty liver disease have an effect?

Original Submission
13 Dec 2023 Submitted Original manuscript
9 Mar 2024 Reviewed Reviewer Report - Imad Tarhoni
29 Mar 2024 Reviewed Reviewer Report
3 Apr 2024 Author responded Author comments - Guofeng Zhou
Resubmission - Version 2
3 Apr 2024 Submitted Manuscript version 2
4 Apr 2024 Author responded Author comments - Guofeng Zhou
Resubmission - Version 3
4 Apr 2024 Submitted Manuscript version 3
7 Apr 2024 Reviewed Reviewer Report
18 Apr 2024 Author responded Author comments - Guofeng Zhou
Resubmission - Version 4
18 Apr 2024 Submitted Manuscript version 4
Publishing
19 Apr 2024 Editorially accepted
27 Apr 2024 Article published 10.1186/s12885-024-12295-6

You can find further information about peer review here.

Back to article page